Profile	GDS4147 / 201849_at
Title	Relapsing-remitting multiple sclerosis therapy of Interferon-β Betaferon or Rebif: peripheral mononuclear blood cells
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM641342	Patient 4, baseline	6.09	75
GSM641346	Patient 13, baseline	7.21	82
GSM641350	Patient 999, baseline	8.39	90
GSM641354	Patient 998, baseline	8.11	88
GSM641358	Patient 108, baseline	5.93	73
GSM641362	Patient 112, baseline	6.92	81
GSM641366	Patient 113, baseline	6.01	73
GSM641370	Patient 116, baseline	6.68	79
GSM641343	Patient 4, 3 month of BETAFERON	6.11	74
GSM641351	Patient 999, 3 month of BETAFERON	8.56	91
GSM641355	Patient 998, 3 month of BETAFERON	8.07	88
GSM641359	Patient 108, 3 month of BETAFERON	6.22	75
GSM641347	Patient 13, 3 month of REBIF	7.05	81
GSM641363	Patient 112, 3 month of REBIF	6.43	77
GSM641367	Patient 113, 3 month of REBIF	6.05	73
GSM641371	Patient 116, 3 month of REBIF	6	74
GSM641344	Patient 4, 12 month of BETAFERON	6.57	78
GSM641352	Patient 999, 12 month of BETAFERON	8.54	91
GSM641356	Patient 998, 12 month of BETAFERON	8.58	91
GSM641360	Patient 108, 12 month of BETAFERON	6.36	76
GSM641348	Patient 13, 12 month of REBIF	8.15	89
GSM641364	Patient 112, 12 month of REBIF	6.6	78
GSM641368	Patient 113, 12 month of REBIF	5.92	72
GSM641372	Patient 116, 12 month of REBIF	5.65	70
GSM641345	Patient 4, 24 month of BETAFERON	6.22	75
GSM641353	Patient 999, 24 month of BETAFERON	8.47	91
GSM641357	Patient 998, 24 month of BETAFERON	8.5	91
GSM641361	Patient 108, 24 month of BETAFERON	5.97	72
GSM641349	Patient 13, 24 month of REBIF	8.58	91
GSM641365	Patient 112, 24 month of REBIF	6.09	74
GSM641369	Patient 113, 24 month of REBIF	5.83	71
GSM641373	Patient 116, 24 month of REBIF	6.56	78